2013 International Symposium on Hodgkin Lymphoma

Advertisement

Advertisement



Oct
16
Today In Oncology
FDA Approves Talazoparib for Deleterious Germline BRCA-Mutated HER2-Negative Locally Advanced or Metastatic Breast Cancer
Study Finds Deep Learning Can Distinguish Recalled-Benign Mammogram Images From Malignant and Negative Cases
FDA Accepts New Drug Application, Grants Priority Review to Selinexor for Pentarefractory Multiple Myeloma
Small Study of Neoadjuvant Combination Checkpoint Blockade in High-Risk Stage III Melanoma
Opioid Use Following Video-Assisted Thoracoscopic Surgery or Open Resection in Early-Stage Lung Cancer
View More 
;
Advertisement
Most Read Stories
KEYNOTE-407: First-Line Pembrolizumab Plus Chemotherapy in Metastatic Squamous NSCLC
Report Examines Shortages of Oncologists, Variation in Cancer Rates
IMpower133: Atezolizumab in Combination With Chemotherapy in Previously Untreated, Extensive-Stage Small Cell Lung Cancer
Cognitive Impairment in Patients With Breast Cancer Treated With Chemotherapy
Immune Checkpoint Blockade and Tumor-Specific Vaccine for Incurable HPV16-Related Cancer
View More 
Most Viewed Videos
Ursula A. Matulonis, MD, and Daniel J. Margul, MD, PhD, on Cervical Cancer and Minimally Invasive Surgery
Jay B. Shah, MD, on Reducing Opioid Use After Urologic Oncology Surgery
Frederick L. Locke, MD, on CAR T-Cell Therapy: Major Milestones
Angela M. Stover, PhD, on Patient-Reported Symptoms: Results From the STAR and PRO-TECT Trials
Lauren P. Wallner, PhD, MPH, on Thyroid Cancer: Reducing Overtreatment With Radioactive Iodine
View More 
© 2018 HSP News Service, L.L.C.
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.